Literature DB >> 16437761

Aspects of taste and compliance in patients with cancer.

Paula Ravasco1.   

Abstract

Taste alterations are common in patients with cancer, and can be the result of the disease itself and/or its treatment(s). Specifically, chemotherapy and/or radiotherapy to the head and neck area have been shown to induce significant taste changes. Alterations in taste are distressing for patients and can lead to food aversions, a reduction in food intake and nutritional deficits. Ultimately, this can lead to weight loss and, in severe cases, malnutrition, which has been associated with poor patient outcomes, including a negative effect on survival. Dietary counselling and advice tailored to the individual can improve nutritional status, and several effective strategies are available to accommodate taste changes and increase nutritional intake. Oral supplements may provide additional nutritional support when dietary intake is insufficient. The success of supplementation depends, however, on the product acceptability and on patient compliance over the long term. Patient compliance is linked to perceived supplement taste, which may be affected by a variety of taste changes reported by patients both before and after therapy, or as a consequence of disease progression. Supplements which offer a variety of flavours are likely to prove beneficial by helping to prevent taste fatigue. In addition, individuals appear to exhibit distinct preferences for particular flavours at different time points during treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437761     DOI: 10.1016/j.ejon.2005.09.003

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  26 in total

1.  Teaching nutrition integration: MUST screening in cancer.

Authors:  Carolina Boléo-Tomé; Mariana Chaves; Isabel Monteiro-Grillo; Maria Camilo; Paula Ravasco
Journal:  Oncologist       Date:  2011-01-27

2.  Evaluation of multiple neurotoxic outcomes in cancer chemotherapy.

Authors:  Bernard Weiss
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.

Authors:  Davide Bomben; Alessandra Bin; Margherita Venturini; Teresa Bulfone; Luca Ghirotto; Valentina Bressan
Journal:  Support Care Cancer       Date:  2019-04-01       Impact factor: 3.603

4.  Long-term follow-up of the potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial.

Authors:  Kate Furness; Mary Anne Silvers; June Savva; Catherine E Huggins; Helen Truby; Terry Haines
Journal:  Support Care Cancer       Date:  2017-06-14       Impact factor: 3.603

Review 5.  Key determinants of energy expenditure in cancer and implications for clinical practice.

Authors:  S A Purcell; S A Elliott; V E Baracos; Q S C Chu; C M Prado
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

Review 6.  A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients.

Authors:  Trina Thorne; Karin Olson; Wendy Wismer
Journal:  Support Care Cancer       Date:  2015-07-11       Impact factor: 3.603

7.  Taste Alteration in Patients Receiving Chemotherapy.

Authors:  Elif Sözeri; Sevinç Kutlutürkan
Journal:  J Breast Health       Date:  2015-04-01

8.  Genome-wide analysis of gene expression in primate taste buds reveals links to diverse processes.

Authors:  Peter Hevezi; Bryan D Moyer; Min Lu; Na Gao; Evan White; Fernando Echeverri; Dalia Kalabat; Hortensia Soto; Bianca Laita; Cherry Li; Shaoyang Anthony Yeh; Mark Zoller; Albert Zlotnik
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

9.  Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy.

Authors:  Karla Sánchez-Lara; Ricardo Sosa-Sánchez; Dan Green-Renner; Cindy Rodríguez; Alessandro Laviano; Daniel Motola-Kuba; Oscar Arrieta
Journal:  Nutr J       Date:  2010-03-24       Impact factor: 3.271

10.  Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.

Authors:  Naoto Okada; Takeshi Hanafusa; Shinji Abe; Chiemi Sato; Toshimi Nakamura; Kazuhiko Teraoka; Masahiro Abe; Kazuyoshi Kawazoe; Keisuke Ishizawa
Journal:  Support Care Cancer       Date:  2016-04-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.